Vindesine
Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).
Year introduced: 1986
PubMed search builder options
Subheadings:
Tree Number(s): D03.132.436.681.827.830, D03.633.100.473.402.681.827.830, D03.633.100.496.500.500.681.827.830
MeSH Unique ID: D014751
Registry Number: RSA8KO39WH
Entry Terms:
- Desacetylvinblastine Amide
- Vindesin
- NSC-245467
- NSC245467
- NSC 245467
- Vindesine Sulfate
- Sulfate, Vindesine
- Compound 112531
- Eldisine
- Enison
Previous Indexing:
Pharmacologic Action: